These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. The polymorphism of the CHRNA5 gene and the strength of nicotine addiction in lung cancer and COPD patients. Wojas-Krawczyk K; Krawczyk P; Biernacka B; Grzybek M; Kołodziej P; Kucharczyk T; Mlak R; Milanowski J Eur J Cancer Prev; 2012 Mar; 21(2):111-7. PubMed ID: 21955800 [TBL] [Abstract][Full Text] [Related]
3. Beyond cigarettes per day. A genome-wide association study of the biomarker carbon monoxide. Bloom AJ; Hartz SM; Baker TB; Chen LS; Piper ME; Fox L; Martinez M; Hatsukami D; Johnson EO; Laurie CC; Saccone NL; Goate A; Bierut LJ Ann Am Thorac Soc; 2014 Sep; 11(7):1003-10. PubMed ID: 25072098 [TBL] [Abstract][Full Text] [Related]
4. CHRNA3 rs1051730 and CHRNA5 rs16969968 polymorphisms are associated with heavy smoking, lung cancer, and chronic obstructive pulmonary disease in a mexican population. Pérez-Morales R; González-Zamora A; González-Delgado MF; Calleros Rincón EY; Olivas Calderón EH; Martínez-Ramírez OC; Rubio J Ann Hum Genet; 2018 Nov; 82(6):415-424. PubMed ID: 29993116 [TBL] [Abstract][Full Text] [Related]
5. Rare, low frequency and common coding variants in CHRNA5 and their contribution to nicotine dependence in European and African Americans. Olfson E; Saccone NL; Johnson EO; Chen LS; Culverhouse R; Doheny K; Foltz SM; Fox L; Gogarten SM; Hartz S; Hetrick K; Laurie CC; Marosy B; Amin N; Arnett D; Barr RG; Bartz TM; Bertelsen S; Borecki IB; Brown MR; Chasman DI; van Duijn CM; Feitosa MF; Fox ER; Franceschini N; Franco OH; Grove ML; Guo X; Hofman A; Kardia SL; Morrison AC; Musani SK; Psaty BM; Rao DC; Reiner AP; Rice K; Ridker PM; Rose LM; Schick UM; Schwander K; Uitterlinden AG; Vojinovic D; Wang JC; Ware EB; Wilson G; Yao J; Zhao W; Breslau N; Hatsukami D; Stitzel JA; Rice J; Goate A; Bierut LJ Mol Psychiatry; 2016 May; 21(5):601-7. PubMed ID: 26239294 [TBL] [Abstract][Full Text] [Related]
7. A candidate gene approach identifies the CHRNA5-A3-B4 region as a risk factor for age-dependent nicotine addiction. Weiss RB; Baker TB; Cannon DS; von Niederhausern A; Dunn DM; Matsunami N; Singh NA; Baird L; Coon H; McMahon WM; Piper ME; Fiore MC; Scholand MB; Connett JE; Kanner RE; Gahring LC; Rogers SW; Hoidal JR; Leppert MF PLoS Genet; 2008 Jul; 4(7):e1000125. PubMed ID: 18618000 [TBL] [Abstract][Full Text] [Related]
8. The CHRNA5-A3-B4 gene cluster in nicotine addiction. Berrettini WH; Doyle GA Mol Psychiatry; 2012 Sep; 17(9):856-66. PubMed ID: 21968931 [TBL] [Abstract][Full Text] [Related]
9. Epidemiology, radiology, and genetics of nicotine dependence in COPD. Kim DK; Hersh CP; Washko GR; Hokanson JE; Lynch DA; Newell JD; Murphy JR; Crapo JD; Silverman EK; Respir Res; 2011 Jan; 12(1):9. PubMed ID: 21232152 [TBL] [Abstract][Full Text] [Related]
10. Mediating effects of smoking and chronic obstructive pulmonary disease on the relation between the CHRNA5-A3 genetic locus and lung cancer risk. Wang J; Spitz MR; Amos CI; Wilkinson AV; Wu X; Shete S Cancer; 2010 Jul; 116(14):3458-62. PubMed ID: 20564069 [TBL] [Abstract][Full Text] [Related]
12. Association of CHRNA4 polymorphisms with smoking behavior in two populations. Han S; Yang BZ; Kranzler HR; Oslin D; Anton R; Gelernter J Am J Med Genet B Neuropsychiatr Genet; 2011 Jun; 156B(4):421-9. PubMed ID: 21445957 [TBL] [Abstract][Full Text] [Related]
13. [Polymorphic Variants of Glutamate Receptor (GRIK5, GRIN2B) and Serotonin Receptor (HTR2A) Genes Are Associated with Chronic Obstructive Pulmonary Disease]. Korytina GF; Akhmadishina LZ; Kochetova OV; Aznabaeva YG; Zagidullin SZ; Victorova TV Mol Biol (Mosk); 2017; 51(4):603-614. PubMed ID: 28900078 [TBL] [Abstract][Full Text] [Related]
14. The CHRNA5-A3 region on chromosome 15q24-25.1 is a risk factor both for nicotine dependence and for lung cancer. Spitz MR; Amos CI; Dong Q; Lin J; Wu X J Natl Cancer Inst; 2008 Nov; 100(21):1552-6. PubMed ID: 18957677 [TBL] [Abstract][Full Text] [Related]
15. Intermediacy and gene-environment interaction: the example of CHRNA5-A3 region, smoking, nicotine dependence, and lung cancer. Wacholder S; Chatterjee N; Caporaso N J Natl Cancer Inst; 2008 Nov; 100(21):1488-91. PubMed ID: 18957674 [No Abstract] [Full Text] [Related]
16. Association Between Nicotine-dependent Gene Polymorphism and Smoking Cessation in Patients With Lung Cancer. Gu F; Zhao C; Jiang T; Li X; Mao Y; Zhou C Clin Lung Cancer; 2020 Mar; 21(2):171-176. PubMed ID: 31402126 [TBL] [Abstract][Full Text] [Related]
17. Role of nicotine dependence on the relationship between variants in the nicotinic receptor genes and risk of lung adenocarcinoma. Tseng TS; Park JY; Zabaleta J; Moody-Thomas S; Sothern MS; Chen T; Evans DE; Lin HY PLoS One; 2014; 9(9):e107268. PubMed ID: 25233467 [TBL] [Abstract][Full Text] [Related]
18. Resequencing of nicotinic acetylcholine receptor genes and association of common and rare variants with the Fagerström test for nicotine dependence. Wessel J; McDonald SM; Hinds DA; Stokowski RP; Javitz HS; Kennemer M; Krasnow R; Dirks W; Hardin J; Pitts SJ; Michel M; Jack L; Ballinger DG; McClure JB; Swan GE; Bergen AW Neuropsychopharmacology; 2010 Nov; 35(12):2392-402. PubMed ID: 20736995 [TBL] [Abstract][Full Text] [Related]
19. Association between a 15q25 gene variant, nicotine-related habits, lung cancer and COPD among 56,307 individuals from the HUNT study in Norway. Gabrielsen ME; Romundstad P; Langhammer A; Krokan HE; Skorpen F Eur J Hum Genet; 2013 Nov; 21(11):1293-9. PubMed ID: 23443019 [TBL] [Abstract][Full Text] [Related]
20. Chr15q25 genetic variant (rs16969968) independently confers risk of lung cancer, COPD and smoking intensity in a prospective study of high-risk smokers. Hopkins RJ; Duan F; Gamble GD; Chiles C; Cavadino A; Billings P; Aberle D; Young RP Thorax; 2021 Mar; 76(3):272-280. PubMed ID: 33419953 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]